相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存:
100
- 供应商:
上海酶研生物科技有限公司
- 英文名:
ECM-NG (Endothelial Cell Medium-NG)
- 规格:
500ml/T
|
货号 |
1001-NG |
|
产地 |
北美 |
|
缩写 |
ECM-NG |
|
规格 |
500ml |
|
用途 |
科研 |
|
储存 |
4度,-20度 |
|
运输 |
胶冰 |
Endothelial cell medium – no glutamine (ECM-NG), when used with Endothelial Cell Growth Supplement (ECGS) and FBS is a complete medium designed for optimal growth of normal endothelial cells?in vitro. It is a sterile, liquid medium which contains essential and non-essential amino acids, vitamins, organic and inorganic compounds, hormones, growth factors, trace minerals and a low concentration of fetal bovine serum (5%). The medium is HEPES and bicarbonate buffered and has a pH of 7.4 when equilibrated in an incubator with an atmosphere of 5% CO2/95% air. The medium is formulated (quantitatively and qualitatively) to provide an optimally balanced nutritional environment that selectively supports the growth of normal endothelial cells?in vitro.
ECM-NG does not contain L-glutamine,?an essential amino acid that is unstable in solution at 37°C. ECM-NG should be supplemented with L-glutamine (L-Glu; cat #0813) or stable L-glutamine dipeptide, L-alanyl-l-glutamine (LALG, Cat. #0733). The recommended LALG concentration ranges from 2mM to 10mM but may vary with culture conditions.
1.) Zhou H, Ji X, Wu Y, Xuan J, Qi Z, Shen L, Lan L, Li Q, Yin Z, Li Z, Zhao Z. (2014) 'A Dual-Role of Gu-4 in Suppressing HMGB1 Secretion and Blocking HMGB1 Pro-Inflammatory Activity during Inflammation.'
2.) Zhao N, Watson N, Xu Z, Chen Y, Waterman J, Sankar J, Zhu D. (2014) 'In Vitro Biocompatibility and Endothelialization of Novel Magnesium-Rare Earth Alloys for Improved Stent Applications.'
3.) Yang J, Wang Q, Qiao C, Lin Z, Li X, Huang Y, Zhou T, Li Y, Shen B, Lv M, Feng J. (2014) 'Potent anti-angiogenesis and anti-tumor activity of a novel human anti-VEGF antibody, MIL60.'
4.) Xu Q, Xia P, Li X, Wang W, Liu Z, Gao X. (2014) 'Tetramethylpyrazine Ameliorates High Glucose-Induced Endothelial Dysfunction by Increasing Mitochondrial Biogenesis.'
5.) Xing S, Yang X, Li W, Bian F, Wu D, Chi J, Xu G, Zhang Y, Jin S. (2014) 'Salidroside Stimulates Mitochondrial Biogenesis and Protects against H 2 O 2-Induced Endothelial Dysfunction.'
6.) Voigt J, Christensen J, Shastri VP. (2014) 'Differential uptake of nanoparticles by endothelial cells through polyelectrolytes with affinity for caveolae.'
7.) Wang Q, Yang J, Tang K, Luo L, Wang L, Tian L, Jiang Y, Feng J, Li Y, Shen B, Ly M, Huang Y. (2014) 'Pharmacological characteristics and efficacy of a novel anti-angiogenic antibody FD006 in corneal neovascularization.'
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验
1.) Zhou H, Ji X, Wu Y, Xuan J, Qi Z, Shen L, Lan L, Li Q, Yin Z, Li Z, Zhao Z. (2014) 'A Dual-Role of Gu-4 in Suppressing HMGB1 Secretion and Blocking HMGB1 Pro-Inflammatory Activity during Inflammation.'
2.) Zhao N, Watson N, Xu Z, Chen Y, Waterman J, Sankar J, Zhu D. (2014) 'In Vitro Biocompatibility and Endothelialization of Novel Magnesium-Rare Earth Alloys for Improved Stent Applications.'
3.) Yang J, Wang Q, Qiao C, Lin Z, Li X, Huang Y, Zhou T, Li Y, Shen B, Lv M, Feng J. (2014) 'Potent anti-angiogenesis and anti-tumor activity of a novel human anti-VEGF antibody, MIL60.'
4.) Xu Q, Xia P, Li X, Wang W, Liu Z, Gao X. (2014) 'Tetramethylpyrazine Ameliorates High Glucose-Induced Endothelial Dysfunction by Increasing Mitochondrial Biogenesis.'
5.) Xing S, Yang X, Li W, Bian F, Wu D, Chi J, Xu G, Zhang Y, Jin S. (2014) 'Salidroside Stimulates Mitochondrial Biogenesis and Protects against H 2 O 2-Induced Endothelial Dysfunction.'
6.) Voigt J, Christensen J, Shastri VP. (2014) 'Differential uptake of nanoparticles by endothelial cells through polyelectrolytes with affinity for caveolae.'
7.) Wang Q, Yang J, Tang K, Luo L, Wang L, Tian L, Jiang Y, Feng J, Li Y, Shen B, Ly M, Huang Y. (2014) 'Pharmacological characteristics and efficacy of a novel anti-angiogenic antibody FD006 in corneal neovascularization.'
技术资料暂无技术资料 索取技术资料





